McKee Amy E — SEC Form 4 filings
SEC reporting owner CIK 1883764. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-14 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 19,780 shares, $154,637 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 11,180 shares @ $8.97 ($100,285) in BIOCRYST PHARMACEUTICALS INC, filed 2026-05-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | 10 | — | 2 legs · 19,780 sh · $154,637 | 11 |
Form 4 filings — McKee Amy E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 644 @ $9.70 | EDGAR |
| 2026-06-15 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 15,294 @ $0 · Grant/award (A): 33,540 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 631 @ $8.91 | EDGAR |
| 2026-05-19 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Sale (S): 11,180 @ $8.97 | EDGAR |
| 2026-03-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 642 @ $8.75 | EDGAR |
| 2025-12-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 783 @ $7.18 | EDGAR |
| 2025-09-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 676 @ $8.31 | EDGAR |
| 2025-06-16 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 27,181 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Sale (S): 8,600 @ $6.32 | EDGAR |
| 2024-06-14 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 6,820 @ $0 · Grant/award (A): 49,933 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1883764 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →